Results per Page: 20
  • 5
  • 10
  • 20
  • 50
  • 100
HVTN at the 24th International AIDS Conference in Montreal

HVTN at the 24th International AIDS Conference in Montreal

HVTN researchers and faith leaders will address HIV and SARS-CoV-2, neutralizing antibodies, future directions for research, lessons from COVID-19 community engagement, overcoming HIV stigma and discrimination, and more
News Releases - July 28, 2022
CoVPN Trial: Novavax’s Traditional COVID-19 Vaccine Correlates to Strong Antibody Response, Protection Against SARS-CoV-2

CoVPN Trial: Novavax’s Traditional COVID-19 Vaccine Correlates to Strong Antibody Response, Protection Against SARS-CoV-2

Response comparable to mRNA vaccines and if authorized, could help bolster global vaccine supplies
News Releases - June 28, 2022
CoVPN Impact Winner

CoVPN Impact Winner

Community Compass - December 01, 2021

News on HVTN

Read MORE
Fauci visits Fred Hutch, discusses pandemics, vaccines and scientific misinformation NIAID director’s determined spirit recognized with honorary Hutch Award August 10, 2022
Test of a new 'germline-targeting' HIV vaccine prepares to launch Vaccine’s unique protein designed to start process of building powerful antibodies against AIDS virus May 19, 2022
Highlights of Fred Hutch science in 2021 From COVID-19 to cancer, Hutch scientists pursued new ideas to save lives December 20, 2021
World AIDS Day 2021: Let's give the gifts of hope and focus to HIV research HIV scientific infrastructure paved the way for the world’s COVID-19 response. Now, it’s time to return the favor. December 1, 2021